Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1996
03/21/1996CA2199264A1 System and method of automatically generating chemical compounds with desired properties
03/21/1996CA2198361A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996CA2198263A1 Method for detection of malfolded protein
03/21/1996CA2198248A1 Polypeptides with fc binding ability
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702028A2 Binding agent for growth factor
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells
03/20/1996EP0701615A1 Mutant polypeptide of protein kinase c, nucleic acid sequences coding for said polypeptide and use thereof
03/20/1996EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell
03/20/1996EP0701607A1 Mammals lacking expression of cd28 transgenic
03/20/1996EP0701606A1 Method of enhancing thrombolysis
03/20/1996EP0701572A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
03/20/1996EP0701569A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701567A1 New peptides derivatives
03/20/1996EP0701563A1 Gene transfer for treating a connective tissue of a mammalian host
03/20/1996EP0701450A1 Recombinant viruses and their use in gene therapy
03/20/1996EP0701448A1 Amplification of the vitamin b 12? uptake system using polymers
03/20/1996EP0701447A1 Cyclohexapeptidyl propanolamine compounds
03/20/1996EP0701446A1 Hemoregulatory peptides
03/20/1996EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein
03/20/1996EP0659083A4 Prevention and treatment of peripheral neuropathy.
03/20/1996EP0571417B1 Combination of igf-i and igfbp for anabolism
03/20/1996EP0456842B1 Medicinal application of m-csf
03/20/1996EP0456686B1 Excretory/secretory antigens of tapeworm (cysticercus cellulosae) for use in immunodiagnosis and vaccine preparation
03/20/1996EP0449973B1 Polypeptide-polymer conjugates active in wound healing
03/20/1996EP0401347B1 Use of transferrin to combat the toxic effects of endotoxins in endotoxemia
03/20/1996EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders
03/20/1996CN1031344C Process for preparing peptides inhibiting maturation of T-lymphocytes and activity of macrophages
03/19/1996US5500434 Mixture of trandolapril and felodipine
03/19/1996US5500415 Process for the preparation of spherules of active principles and emulsions containing the spherules
03/19/1996US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases
03/19/1996US5500413 Process for manufacture of 1-deamino-8-D-arginine vasopressin
03/19/1996US5500412 Selective stimulation and inhibition of receptor signals, wound healing, antitumor agents
03/19/1996US5500411 Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins
03/19/1996US5500409 Method for inhibiting collagen synthesis by keloid fibroblasts
03/19/1996US5500362 Chimeric antibody with specificity to human B cell surface antigen
03/19/1996US5500354 Genetic engineering
03/19/1996US5500346 Monoclonal antibodies to human influx peptide transporter
03/19/1996US5500230 Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
03/19/1996US5500225 Monitoring melatonin levels and administering to compensate for deficiencies
03/19/1996US5500224 Pharmaceutical compositions containing nanocapsules
03/19/1996CA2073012C Method for isolating factor viii
03/19/1996CA2071653C Method of preparing activated protein c
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/17/1996CA2158395A1 Coccidiosis poultry vaccine
03/14/1996WO1996007915A1 Predictive test for hepatitis-b resistance
03/14/1996WO1996007754A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
03/14/1996WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996WO1996007740A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007738A2 Modified human c3 proteins
03/14/1996WO1996007737A1 A novel haemopoietin receptor
03/14/1996WO1996007735A1 Novel deoxyribonuclease
03/14/1996WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996WO1996007673A1 Monocyte chemotaxin inducible proteins
03/14/1996WO1996007440A2 Methods and apparatus for the delivery of solid drug compositions
03/14/1996WO1996007433A1 Gene therapy drug for cancer, medicinal composition, and therapeutic method
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007428A1 Peptide compositions capable of down regulating an antigen specific immune response
03/14/1996WO1996007425A1 Method of blocking the sec receptor
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996WO1996007422A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996WO1996007421A2 An antiulcer medicine comprising a protein possessing all growth factor activity and a proton pump inhibitor
03/14/1996WO1996007418A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996WO1996007417A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996WO1996007416A1 Estrogens and parathyroid hormone for treating osteoporosis
03/14/1996WO1996007400A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
03/14/1996WO1996007399A1 Sustained release preparation containing metal salt of a peptide
03/14/1996WO1996007398A2 Sustained release of peptides from pharmaceutical compositions
03/14/1996WO1996007397A2 Delivery of solid drug compositions
03/14/1996WO1996007329A1 Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
03/14/1996WO1996007322A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996WO1996007318A1 Buffer system for increasing seroconversion efficiency
03/14/1996WO1996006168A3 Retinoblastoma protein-interacting zinc finger proteins
03/14/1996WO1996005307A3 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996005306A3 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
03/14/1996WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
03/14/1996WO1996002556A3 Oligonucleotides with anti-mdr-1 gene activity
03/14/1996WO1995035376A3 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
03/14/1996WO1995035373A3 Nucleic acid molecules encoding human contactin
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996DE4430127A1 Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat Combination preparation containing cyclosporin A or FK506 and a xanthine derivative
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199478A1 Bacteriophage-encoded enzymes for the treatment and prevention of dental caries and periodontal diseases
03/14/1996CA2199265A1 Method of sensitizing tumor cells with adenovirus e1a
03/14/1996CA2199262A1 Use of il-4 for potentiation of chemotherapeutic agents
03/14/1996CA2199252A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
03/14/1996CA2199251A1 Phosphonates and parathyroid hormone for osteoporosis
03/14/1996CA2199250A1 Estrogens and parathyroid hormone for treating osteoporosis
03/14/1996CA2199180A1 Method of blocking the sec receptor
03/14/1996CA2198935A1 Monoclonal recombinant anti-rhesus d (d7c2) antibody
03/14/1996CA2198869A1 Peptide compositions capable of down regulating an antigen specific immune response
03/14/1996CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein
03/14/1996CA2198707A1 Predictive test for hepatitis-b resistance
03/14/1996CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
1 ... 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 ... 3163